Nathan Cracraft

VP, IT & Facilities at Vaxcyte

Nathan has spent more than 25 years dedicated to IT predominately within the life sciences industry. He brings significant technology leadership expertise focused on building scalable and compliant IT strategies, blueprints, solutions and operational organizations. Additionally, in recent years, Nathan has broadened his responsibilities to include facilities planning and management.

Prior to joining Vaxcyte, Nathan served as the Vice President of IT and Facilities of Dermira, Inc. through its acquisition by Eli Lilly and Company. In this role, he helped scale the company’s IT technology infrastructure and support operations ahead of a successful commercial product launch. Previously, Nathan held technology leadership roles at Gilead Sciences, Inc., Johnson and Johnson and Ernst and Young. Nathan received his BS from Indiana University in Bloomington, Indiana.

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Vaxcyte

2 followers

Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.


Industries

Employees

11-50

Links